Serina Therapeutics Files 8-K
Ticker: SER · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulation-fd, financials
TL;DR
Serina Therapeutics (formerly AgeX) filed an 8-K on 4/7/25 for Reg FD and financials.
AI Summary
Serina Therapeutics, Inc. filed an 8-K on April 7, 2025, to report information under Regulation FD and to file financial statements and exhibits. The company, formerly known as AgeX Therapeutics, Inc., is incorporated in Delaware and headquartered in Huntsville, Alabama.
Why It Matters
This filing indicates Serina Therapeutics is making required disclosures and submitting financial documents, which is standard for public companies but important for investors to monitor.
Risk Assessment
Risk Level: low — This is a routine filing for a public company and does not contain specific material events or financial performance data that would indicate a change in risk.
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Registrant
- AgeX Therapeutics, Inc. (company) — Former company name
- April 7, 2025 (date) — Date of report
- Huntsville, Alabama (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Serina Therapeutics, Inc.?
The primary purpose of this 8-K filing is to disclose information under Regulation FD and to submit financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on April 7, 2025.
What was Serina Therapeutics, Inc. formerly known as?
Serina Therapeutics, Inc. was formerly known as AgeX Therapeutics, Inc.
In which state is Serina Therapeutics, Inc. incorporated?
Serina Therapeutics, Inc. is incorporated in Delaware.
What is the address of Serina Therapeutics, Inc.'s principal executive offices?
The address of Serina Therapeutics, Inc.'s principal executive offices is 601 Genome Way, Suite 2001, Huntsville, Alabama 35806.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding Serina Therapeutics, Inc. (SER).